Delos Wealth Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-71,880
Closed -$1.35M 349
2023
Q3
$1.35M Sell
71,880
-1,086
-1% -$20.6K 1.64% 22
2023
Q2
$1.37M Buy
72,966
+3,490
+5% +$70.4K 1.75% 20
2023
Q1
$1.42M Buy
+69,476
New +$1.4M 1.79% 19

Other funds holding BTAL

Delos Wealth Advisors's BTAL Position: Q4 2023 in Review

Delos Wealth Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2023, closing a stake of 71,880 shares — an estimated $1.35M sold.

Delos Wealth Advisors first reported a position in BTAL in Q1 2023 and held it in 3 quarters. The position peaked at $1.42M in Q1 2023. 75 funds tracked by Wall St. Rank hold BTAL as of Q4 2023.

  • Delos Wealth Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2023 after selling out during the quarter.
  • Delos Wealth Advisors sold 71,880 AGF US Market Neutral Anti-Beta Fund shares in Q4 2023, an estimated $1.35M.
  • Delos Wealth Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2023 and held it in 3 quarters.
  • Delos Wealth Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $1.42M in Q1 2023.
  • 75 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2023.

Based on Delos Wealth Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.